- Home
- CIA vs NTHI Comparison
CIA vs NTHI Comparison
Compare CIA & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIA
- NTHI
- Stock Information
- Founded
- CIA 1969
- NTHI 2008
- Country
- CIA United States
- NTHI United States
- Employees
- CIA N/A
- NTHI N/A
- Industry
- CIA Life Insurance
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- CIA Finance
- NTHI Health Care
- Exchange
- CIA Nasdaq
- NTHI Nasdaq
- Market Cap
- CIA 261.8M
- NTHI 211.9M
- IPO Year
- CIA N/A
- NTHI N/A
- Fundamental
- Price
- CIA $5.57
- NTHI $9.80
- Analyst Decision
- CIA
- NTHI
- Analyst Count
- CIA 0
- NTHI 0
- Target Price
- CIA N/A
- NTHI N/A
- AVG Volume (30 Days)
- CIA 108.3K
- NTHI 42.0K
- Earning Date
- CIA 11-05-2025
- NTHI 11-19-2025
- Dividend Yield
- CIA N/A
- NTHI N/A
- EPS Growth
- CIA N/A
- NTHI N/A
- EPS
- CIA 0.22
- NTHI N/A
- Revenue
- CIA $245,943,000.00
- NTHI $59,990.00
- Revenue This Year
- CIA $4.22
- NTHI N/A
- Revenue Next Year
- CIA $4.46
- NTHI N/A
- P/E Ratio
- CIA $25.33
- NTHI N/A
- Revenue Growth
- CIA N/A
- NTHI N/A
- 52 Week Low
- CIA $2.90
- NTHI $3.20
- 52 Week High
- CIA $6.08
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- CIA 51.82
- NTHI N/A
- Support Level
- CIA $5.29
- NTHI N/A
- Resistance Level
- CIA $5.67
- NTHI N/A
- Average True Range (ATR)
- CIA 0.30
- NTHI 0.00
- MACD
- CIA -0.03
- NTHI 0.00
- Stochastic Oscillator
- CIA 35.67
- NTHI 0.00
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).